SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921530-99-000010
Filing Date
1999-01-15
Accepted
1999-01-15 00:00:00
Documents
1
Group Members
GEORGE SOROSSOROS FUND MANAGEMENT LLCSTANLEY F. DRUCKENMILLER

Document Format Files

Seq Description Document Type Size
1 AMEND. # 1 TO 13G RE CORTEX PHARMACEUTICALS, INC. SC 13G/A 14144
  Complete submission text file 0000921530-99-000010.txt   16250
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Subject) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-40457 | Film No.: 99507338
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKIN, GUMP, STRAUSS,HAUER,FELD, 399 PARK AVENUE NEW YORK NY 10022
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 2128721054
SOROS FUND MANAGEMENT LLC (Filed by) CIK: 0001029160 (see all company filings)

IRS No.: 133914976 | State of Incorp.: DE | Fiscal Year End: 1231